Abstract Number: 2294 • 2019 ACR/ARP Annual Meeting
Contraception Documentation Rates in Women with Rheumatic Diseases on Teratogenic Medications in an Academic Rheumatology Clinic
Background/Purpose: Rheumatic diseases are prevalent among women of childbearing age; their treatment often requires medications that potentially affect a woman’s fertility and are teratogenic. Prior…Abstract Number: 2295 • 2019 ACR/ARP Annual Meeting
Burden of Systemic Lupus Erythematosus Among Korean Women in Childbearing Years Based on the National Health Insurance Service Data
Background/Purpose: Most women with systemic lupus erythematosus (SLE) are diagnosed with the disease in their reproductive ages, but the burden of SLE among women in…Abstract Number: 2296 • 2019 ACR/ARP Annual Meeting
Assisted Reproductive Technology in Patients with Inflammatory and Autoimmune Rheumatic Disease
Background/Purpose: Women with chronic inflammatory and autoimmune diseases increasingly solicit assisted reproductive techniques (ART) due to infertility, but there is little information about success rates…Abstract Number: 2297 • 2019 ACR/ARP Annual Meeting
Anti-TNF-α Exposure During Pregnancy: Impact on the Neonate’s Immune System
Background/Purpose: Up to half of pregnant patients with rheumatic diseases experience disease activity which can increase the risk of pregnancy complications and poor disease outcomes. Treatment…Abstract Number: 2298 • 2019 ACR/ARP Annual Meeting
Interstitial Lung Disease Is Associated with Distinct Fine Specificities of Anti-Carbamylated Peptide/Protein Antibodies in Rheumatoid Arthritis
Background/Purpose: Interstitial lung disease (ILD) is a common and severe complication of rheumatoid arthritis (RA). It has been associated with the presence of ACPA. Anti-carbamylated…Abstract Number: 2299 • 2019 ACR/ARP Annual Meeting
The Course of Disability in Early Rheumatoid Arthritis over 10 Years of Follow-up in Women and Men – Comparison with the General Population
Background/Purpose: Patients with rheumatoid arthritis (RA) are known to have increased risk of disability. The aim of this study was to investigate the course of…Abstract Number: 2300 • 2019 ACR/ARP Annual Meeting
Risk Factors for Transfusion and Use of Tranexemic Acid in Patients with Rheumatoid Arthritis Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
Background/Purpose: Utilization of total hip (THA) and total knee arthroplasty (THA) remains high for patients with RA, and most patients have moderate to high disease…Abstract Number: 2301 • 2019 ACR/ARP Annual Meeting
Profile of Renal Function in Patient Suffering from Rheumatoid Arthritis
Background/Purpose: Many medications used in the treatment of rheumatoid arthritis (RA) impact renal function. Some of these may be contraindicated in the presence of a…Abstract Number: 2302 • 2019 ACR/ARP Annual Meeting
Comparison Between Fibromyalgia and Neuropathic Pain in Patients with Established Rheumatoid Arthritis
Background/Purpose: Our objectives were (1) to identify similarities and differences of pain symptoms identified by fibromyalgia (FM) and neuropathic pain (NP) screening tool (2) to…Abstract Number: 2303 • 2019 ACR/ARP Annual Meeting
Emotional and Social Determinants of Health Increase Office Communication for Patients with Rheumatoid Arthritis
Background/Purpose: In RA patients, anxiety and depression are associated with higher disease activity and worse outcomes. We hypothesized that in RA patients, poorer mental health…Abstract Number: 2304 • 2019 ACR/ARP Annual Meeting
Bone Microstructure of Patients with Rheumatoid Arthritis: A HR-pQCT Study
Background/Purpose: In rheumatoid arthritis (RA), it has been reported that osteoclast are activated by immune complexes, anti-CCP antibodies (ACPAs), and inflammatory cytokines. The purpose of…Abstract Number: 2305 • 2019 ACR/ARP Annual Meeting
Multimorbidity May Worsen Fatigue in Patients with Rheumatoid Arthritis
Background/Purpose: Fatigue is a pervasive problem for many patients with rheumatoid arthritis (RA) that often persists despite treatment with effective disease-modifying therapies. Recent studies have…Abstract Number: 2306 • 2019 ACR/ARP Annual Meeting
Prevalent and Incident Multimorbidity in Rheumatoid Arthritis: A Population-Based Cohort Study
Background/Purpose: Multimorbidity is associated with increased risk of adverse outcomes in patients with rheumatoid arthritis (RA). Multiple studies have suggested increased burden of multimorbidity in…Abstract Number: 2307 • 2019 ACR/ARP Annual Meeting
Intermetatarsal Bursitis Is Prevalent in Patients with Established Rheumatoid Arthritis and Is Associated with Anti-CCP and RF
Background/Purpose: Ultrasound is sensitive for detection of inflammatory changes in patients with rheumatoid arthritis (RA). Intermetatarsal bursitis (IMB) may be detected by use of longitudinal…Abstract Number: 2308 • 2019 ACR/ARP Annual Meeting
The Interaction Between Human Leukocyte Antigen Class II Alleles and Seroprotection to Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A post-hoc Analysis
Background/Purpose: There are few studies that have looked into the role of human leukocyte antigen (HLA) class II alleles in seroprotection to influenza, especially in…
ACR Meeting Abstracts